Hims & Hers Health, Inc. Warrants, each whole warrant exercisable for one Class A Common Stock at an
HIMS.WS
HIMS.WS was delisted on the 6th of August, 2021.
19 hedge funds and large institutions have $14M invested in Hims & Hers Health, Inc. Warrants, each whole warrant exercisable for one Class A Common Stock at an in 2021 Q1 according to their latest regulatory filings, with 19 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ICM
Ionic Capital Management
New York
|
+$5.79M |
| 2 |
AC
Athanor Capital
New York
|
+$3.12M |
| 3 |
RA
Royce & Associates
New York
|
+$1.74M |
| 4 |
SCM
Soleus Capital Management
Greenwich,
Connecticut
|
+$599K |
| 5 |
LP
LMR Partners
London,
United Kingdom
|
+$561K |
Top Sellers
HIMS.WS Hedge Fund Activity: Q1 2021 in Review
19 of the 5,711 institutional investors tracked by Wall St. Rank reported a position in Hims & Hers Health, Inc. Warrants, each whole warrant exercisable for one Class A Common Stock at an (HIMS.WS) for Q1 2021, worth a combined $14M.
Buyers outnumbered sellers: 19 funds opened new HIMS.WS positions and 0 closed out — a net gain of 19 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Ionic Capital Management, opening a new position worth an estimated $5.79M.
- 19 institutional investors held Hims & Hers Health, Inc. Warrants, each whole warrant exercisable for one Class A Common Stock at an (HIMS.WS) as of Q1 2021, up from 0 in Q4 2020.
- Funds reported $14M of Hims & Hers Health, Inc. Warrants, each whole warrant exercisable for one Class A Common Stock at an stock for Q1 2021.
- 19 funds opened new Hims & Hers Health, Inc. Warrants, each whole warrant exercisable for one Class A Common Stock at an positions in Q1 2021 and 0 closed out, a net change of +19 holders.
- The largest Hims & Hers Health, Inc. Warrants, each whole warrant exercisable for one Class A Common Stock at an buyer in Q1 2021 was Ionic Capital Management, an estimated $5.79M added.
Based on aggregated 13F filings for Q1 2021.